Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Crazy About Suffolk Bancorp (SUBK)

Page 1 of 2

Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required to invest in a hedge fund and most successful hedge funds won’t accept your savings unless you commit at least $5 million) by pinpointing winning small-cap stocks. There is little or no publicly-available information at all on some of these small companies, which makes it hard for an individual investor to pin down a winner within the small-cap space. However, hedge funds and other big asset managers can do the due diligence and analysis for you instead, thanks to their highly-skilled research teams and vast resources to conduct an appropriate evaluation process. Looking for potential winners within the small-cap galaxy of stocks? We believe following the smart money is a good starting point.

Is Suffolk Bancorp (NASDAQ:SUBK) the right pick for your portfolio? The smart money is buying. The number of bullish hedge fund bets went up by 1 lately. SUBK was in 10 hedge funds’ portfolios at the end of September. There were 9 hedge funds in our database with SUBK holdings at the end of the previous quarter. At the end of this article we will also compare SUBK to other stocks, including Xueda Education Group (ADR) (NYSE:XUE), Arlington Asset Investment Corp (NYSE:AI), and Wausau Paper Corp. (NYSE:WPP) to get a better sense of its popularity.

Follow Suffolk Bancorp (NASDAQ:SCNB)
Trade (NASDAQ:SCNB) Now!

If you’d ask most shareholders, hedge funds are seen as underperforming, outdated financial vehicles of yesteryear. While there are over 8000 funds trading at the moment, Our researchers look at the masters of this group, around 700 funds. It is estimated that this group of investors preside over bulk of all hedge funds’ total asset base, and by paying attention to their best picks, Insider Monkey has figured out a number of investment strategies that have historically surpassed Mr. Market. Insider Monkey’s small-cap hedge fund strategy beat the S&P 500 index by 12 percentage points per annum for a decade in their back tests.

Keeping this in mind, we’re going to take a peek at the fresh action encompassing Suffolk Bancorp (NASDAQ:SUBK).

How have hedgies been trading Suffolk Bancorp (NASDAQ:SUBK)?

Heading into Q4, a total of 10 of the hedge funds tracked by Insider Monkey held long positions in this stock, an increase of 11% from one quarter earlier. With the smart money’s sentiment swirling, there exists an “upper tier” of notable hedge fund managers who were increasing their holdings substantially (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, Basswood Capital, managed by Matthew Lindenbaum, holds the biggest position in Suffolk Bancorp (NASDAQ:SUBK). The fund reportedly holds a $31.8 million position in the stock, comprising 1.6% of its 13F portfolio. The second most bullish fund manager is Emanuel J. Friedman of EJF Capital, with a $12.6 million position; 0.6% of its 13F portfolio is allocated to the company. Remaining peers that are bullish consist of Jim Simons’s Renaissance Technologies, Neil Chriss’s Hutchin Hill Capital and Fred Cummings’s Elizabeth Park Capital Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!